Hooper R Markert (Hooper Markert)

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 3

Top Topics

Long Non Coding Rna

Top Venues

Cancer gene therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Colin H Quinn, Andee M Beierle, Sara Claire Hutchins, Raoud Marayati, Laura V Bownes, Jerry E Stewart, Hooper R Markert, Michael H Erwin, Jamie M Aye, Karina J Yoon, Gregory K Friedman, Christopher D Willey, James M Markert, Elizabeth Ann Beierle
Targeting High-Risk Neuroblastoma Patient-Derived Xenografts with Oncolytic Virotherapy. Cancers 14 (3) (2022)
Laura V Bownes, Adele P Williams, Raoud Marayati, Laura L Stafman, Hooper R Markert, Colin H Quinn, Nikita Wadhwani, Jamie M Aye, Jerry E Stewart, Karina J Yoon, Elizabeth Mroczek-Musulman, Elizabeth A Beierle
EZH2 inhibition decreases neuroblastoma proliferation and in vivo tumor growth. PloS one 16 (3) (2021)
Raoud Marayati, Laura L Stafman, Adele P Williams, Laura V Bownes, Colin H Quinn, Hooper R Markert, Juliet L Easlick, Jerry E Stewart, David K Crossman, Elizabeth Mroczek-Musulman, Elizabeth Ann Beierle
CRISPR/Cas9-mediated knockout of PIM3 suppresses tumorigenesis and cancer cell stemness in human hepatoblastoma cells. Cancer gene therapy (2021)